WHO pauses trial of Hydroxychloriquine for COVID-19

Chennai: The World Health Organization has ‘temporarily’ suspended clinical trials of hydroxychloriquine as a potential treatment for COVID-19 being carried out across a range of countries as a precautionary measure.

Speaking at a virtual press conference, WHO chief Tedros Adhanom Ghebreyesus said the decision came after the publication last week of a study in the Lancet indicating that the using the drug on COVID-19 patients could increase their likelihood of dying.

Ghebreyesus added that the WHO-backed trials had been ‘suspended while the safety is reviewed.’